A comparative analysis of an inflammatory signature in non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) patients revealed that CXCL13 was included among the chemokines elevated in NSCLC patients (86, 87). The gene discussed is CXCL13; the disease is non-small cell lung carcinoma.